TESORAL Trademark

Trademark Overview

On Wednesday, October 22, 2014, a trademark application was filed for TESORAL with the United States Patent and Trademark Office. The USPTO has given the TESORAL trademark a serial number of 86431642. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, March 19, 2016. This trademark is owned by Tesorx Pharma, LLC. The TESORAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services
tesoral

General Information

Serial Number86431642
Word MarkTESORAL
Filing DateWednesday, October 22, 2014
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, March 19, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 30, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTesorx Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 940256805

Trademark Events

Event DateEvent Description
Friday, July 8, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 8, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 21, 2016ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, March 19, 2016ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, August 22, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 22, 2015NON-FINAL ACTION E-MAILED
Saturday, August 22, 2015NON-FINAL ACTION WRITTEN
Thursday, August 20, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 19, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 19, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 19, 2015NON-FINAL ACTION E-MAILED
Thursday, February 19, 2015NON-FINAL ACTION WRITTEN
Thursday, February 19, 2015PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, February 18, 2015TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, February 10, 2015ASSIGNED TO EXAMINER
Thursday, October 30, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 27, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

tesoral pharmaceutical development research services drug products